Image: Tony Coles, Richard Peters. Yumanity
Fresh out of beleaguered Merrimack, Richard Peters jumps into the welcome arms of Tony Coles at Yumanity
In the five-plus years Tony Coles sailed Onyx Pharma ultimately to a multibillion sale to Amgen, he saw Richard Peters — then a senior director of medical affairs — as a “standout star” who had the unique ability to spot an opportunity and seize it.
That’s why, more than 10 years later, Coles finds it “hugely reassuring” to pass Peters the reins to Yumanity Therapeutics, the biotech he co-founded with the late Susan Lindquist to tackle neurodegenerative diseases with a fresh approach.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
